Kramer was the CEO of Emergent BioSolutions, a government contractor hired to mass produce coronavirus vaccine doses, 400 ...
Robert G. Kramer sold nearly 90,000 shares of his stock in Emergent BioSolutions, knowing that large quantities of vaccine ...
Daily Voice on MSN
NY AG sues former Emergent CEO over insider trading
A former biotech CEO pocketed more than $10 million by selling company stock after learning of serious COVID-19 vaccine ...
TRINITY BIOTECH ($TRIB) is expected to release its quarterly earnings data on Thursday, May 22nd before market open, per Finnhub. Analysts are expecting revenue of ...
A surge in deals and financings had the industry abuzz heading into this year’s J.P. Morgan Healthcare Conference. But some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback